Status:
UNKNOWN
Acupoint Stimulation and Cranial Endovascular Treatment
Lead Sponsor:
Zhihong LU
Conditions:
Cerebral Aneurysm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this prospective randomized controlled trial, the subjects will be assigned to group transcutaneous electrical acupoint stimulation (TEAS) and group control (no intervention). The postoperative out...
Eligibility Criteria
Inclusion
- age ≥18 years
- patients scheduled for cranial endovascular treatment
Exclusion
- American Society of Anesthesiologists class Ⅲ or higher
- Hunt-Hess class Ⅲ or higher
- body mass index (BMI) \< 18 kg/㎡ or \> 30kg/㎡
- large or giant cerebral aneurysms with diameters greater than 15mm and minor cerebral aneurysms with diameters less than 3mm
- posterior circulation infarction
- recurrence of an cerebral aneurysms after endovascular procedures or surgical clipping
- severe abnormal coagulation function, severe liver and kidney function damage, or combined with heart and respiratory system failure
- injury or infection of the skin around the acupoint area
- participate in other clinical researchers within 3 months
- history of neurological or psychiatric diseases
- patients with implanted electrophysiological device
- use of sedative or analgesics before surgery
- patients with difficulty in communication
Key Trial Info
Start Date :
July 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT05413460
Start Date
July 26 2022
End Date
June 30 2023
Last Update
December 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing hospital, Fourth military medical university
Xi'an, Shaanxi, China, 710032